Loading
A phase 2 trial of cisplatin, carboplatin, pemetrexed, pembrolizumab and other drugs in lung cancer, run by H. Lee Moffitt Cancer Center and Research Institute, now recruiting.
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC is a phase 2, interventional study registered as NCT06745882 by H. Lee Moffitt Cancer Center and Research Institute, with a registry enrolment figure of 318 participants, started 2025-06-13 and due to reach its primary completion in 2030-01. Interventions recorded: Cisplatin; Carboplatin; Pemetrexed; Pembrolizumab; Abraxane; Paclitaxel. Conditions listed: Non-small Cell Lung Cancer. Primary outcome: Cohort 1: Real World Overall Survival (rwOS); Cohort 2 Arm A: Progression Free Survival (PFS); Cohort 2 Arm B: Progression Free Survival (PFS). Lung eligibility wording from the registry: "* Have histologically or cytologically confirmed, advanced/metastatic NSCLC". Sites: United States. No results are recorded here; the registry entry is the source.
Shares Nab-paclitaxel, Pemetrexed, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel and the tag lung-deep-dive.
Shares Nab-paclitaxel, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Cisplatin and the tag lung-deep-dive.
Shares Nab-paclitaxel, Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Cisplatin, Platinum agents and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Cisplatin, Platinum agents and the tag lung-deep-dive.